company background image
A067370 logo

SunBioInc KOSDAQ:A067370 Stock Report

Last Price

₩8.78k

Market Cap

₩108.1b

7D

9.2%

1Y

-26.2%

Updated

27 Apr, 2024

Data

Company Financials

A067370 Stock Overview

SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide.

A067370 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

SunBio,Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SunBioInc
Historical stock prices
Current Share Price₩8,780.00
52 Week High₩14,500.00
52 Week Low₩7,810.00
Beta0
1 Month Change-3.41%
3 Month Change-9.58%
1 Year Change-26.22%
3 Year Change-75.37%
5 Year Change-42.49%
Change since IPO-20.66%

Recent News & Updates

Recent updates

Shareholder Returns

A067370KR BiotechsKR Market
7D9.2%1.9%2.2%
1Y-26.2%6.5%5.4%

Return vs Industry: A067370 underperformed the KR Biotechs industry which returned 6.5% over the past year.

Return vs Market: A067370 underperformed the KR Market which returned 5.4% over the past year.

Price Volatility

Is A067370's price volatile compared to industry and market?
A067370 volatility
A067370 Average Weekly Movement4.9%
Biotechs Industry Average Movement8.3%
Market Average Movement5.2%
10% most volatile stocks in KR Market11.7%
10% least volatile stocks in KR Market2.4%

Stable Share Price: A067370 has not had significant price volatility in the past 3 months.

Volatility Over Time: A067370's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1997n/an/awww.sunbio.com

SunBio,Inc., a biotech company, develops, produces, and sells biosimilar and biopharmaceutical products, and medical devices based on its technologies of pegylation worldwide. Its biosimilar products include PEG-filgrastim; and PEG-EPO and uricase which is in preclinical stage. The company offers MucoPEG, a medical device for treatment of dry mouth syndrome; and SynoGEL, a viscosupplement for arthritic Knee.

SunBio,Inc. Fundamentals Summary

How do SunBioInc's earnings and revenue compare to its market cap?
A067370 fundamental statistics
Market cap₩108.11b
Earnings (TTM)₩0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A067370 income statement (TTM)
Revenue₩0
Cost of Revenue₩0
Gross Profit₩0
Other Expenses₩0
Earnings₩0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did A067370 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.